Apollo Hospitals Q1 FY27: Revenue up 21%, PAT up 38% YoY
APOLLOHOSP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts more than Nifty 100 and 1.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Apollo Hospitals reported Q1 FY27 results. Consolidated revenue grew 21% YoY to Rs 7,043 crore. PAT rose 38% to Rs 610 crore. Standalone revenue grew 22.5% to Rs 2,656 crore, PAT up 25.5% to Rs 385 crore. EBITDA up 28% YoY. Board appointed Price Waterhouse as new statutory auditor from 2027 AGM, replacing Deloitte. Also approved transfer of FMCG undertaking from Apollo Healthco and granted 46,798 stock options under ESOP 2024.
Strong Q1 with revenue up 21% and PAT up 38% YoY. Price Waterhouse replaces Deloitte as auditor from 2027. Small ESOP grant. Expansion plans continue.